Ambryx Archives | DelveInsight Business Research

Tag: Ambryx

Antibody-Drug Conjugate and Big Pharmaceutical Companies

Apr 1, 2015• Uncategorized

Incyte meets endpoint in second atopic dermatitis trial; NeoTX lands USD 45 M series C; Five Prime Therapeutics’ pancreatic cancer a bust
Business Consultant, Pharma Consultant, Pharma news
Cardiovascular Disease: A major cause of health loss and a global burden
Business Consultant, Pharma Consultant, Snippets
Why should every company working on CAR-T therapy attend CAR TCR Summit Europe?
Chimeric Antigen Receptor (CAR) T-cell Therapy
Promising therapies that might shift Wet Age-related Macular Degeneration Market in the next decade
Articles, Business Consultant, Pharma Consultant
Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&D
Articles, Business Consultant, Pharma Consultant
J&J collaborates with BARDA; Virus kills pancreatic cancer cells; ALX raises USD 105 million for CD47 drug
Business Consultant, News, Pharma Consultant
The epidemic now has a name: COVID-19
Articles, Business Consultant, Pharma Consultant
Good news for Kite’s KTE-X19, and Aquestive’s Libervant; and a commercialization deal between ReForm Biologics, MilliporeSigma
Articles, Business Consultant, Pharma Consultant
Bridging the gap: Nontuberculous mycobacterium Infections Drug Pipeline
Articles, Business Consultant, Pharma Consultant
How Artificial Intelligence is adding value to the Healthcare sector
Articles, Business Consultant, Pharma Consultant